arrow
B

Bang Zheng

Peking University
H指数:32
被引数:4,499

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland

作者更正:托珠单抗与萨利鲁单抗在因COVID-19住院的成人中的比较:英格兰和苏格兰的目标试验模拟

2026-11-040
OAAI
Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland

托珠单抗与萨利尤单抗在因COVID-19住院的成人中的比较:英格兰和苏格兰的目标试验模拟

2026-05-150
OAAI
Long-term kidney outcomes after COVID-19: a matched cohort study using the OpenSAFELY platform

COVID-19后的长期肾脏结局:一项使用OpenSAFELY平台的匹配队列研究

2025-06-180
OA
Conceptual replication and extension of health behavior theories' predictions in the context of COVID-19: Evidence across countries and over time

新型冠状病毒肺炎背景下健康行为理论预测的概念复制和扩展: 国家和时间的证据

2023-12-141
OAAI
Pandemic Boredom: Little Evidence That Lockdown-Related Boredom Affects Risky Public Health Behaviors Across 116 Countries

大流行的无聊: 几乎没有证据表明与锁定相关的无聊会影响116个国家的危险公共卫生行为

EMOTION
IF3.6
2023-12-016
OA
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

英国新型冠状病毒肺炎住院后的多器官MRI结果 (c-more): 一项前瞻性、多中心、观察性队列研究

2023-11-0123
OAAI
Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databases

sotrovimab和molnupiravir预防肾脏替代治疗患者严重新型冠状病毒肺炎结局的比较有效性: 使用OpenSAFELY-UKRR和SRR数据库的观察性研究

2023-08-292
OAAI
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform
2023-07-012
OAAI
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

从post-COVID-19呼吸困难中恢复的决定因素: 英国住院新型冠状病毒肺炎患者和社区对照的前瞻性队列分析

2023-06-0112
OA